Study of VLS-1488 for advanced cancers
Part of Cancer, Skin, Women’s health & pregnancy clinical trials.
This early-phase study tests VLS-1488, a new cancer medicine, in people with advanced cancers that have limited treatment options. It may help by finding a safe dose and whether it can shrink or control tumors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- Your general function is good (ECOG performance status 0–1)
- You have at least one measurable tumor that can be seen on CT scan or MRI (RECIST 1.1)
- You can take medicine by mouth without needing it changed or crushed in a special way
- Your cancer type matches a listed group and you have either no meaningful standard options left (dose escalation) or have had several standard treatments (dose expansion)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called SLV-154 for people whose advanced cancer has not responded to standard treatments. The goal is to see if SLV-154 can shrink tumors or slow cancer growth.
This trial tests two experimental drugs given together to treat advanced solid tumors that have not responded to previous treatments. The goal is to see if the combination helps shrink or control the cancer, and the study is for people who are otherwise in fairly good health.
This trial tests a new targeted drug (LY4175408) for people with certain advanced solid tumors (lung, endometrial, or triple negative breast cancer) who have already tried standard treatments. The goal is to see if the drug is safe and effective.
This study tests a new drug called CVL006 for people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if the drug is safe and how well it works against different types of cancer.
This study tests a combination of two drugs (CVL006 and 9MW2821) for advanced solid tumors, especially head and neck cancer. The goal is to see if the combination can shrink or control the cancer.
This phase 1 trial tests a new drug called SLV-324 for people with solid tumors that have spread and are no longer responding to standard treatments. The goal is to see if the drug is safe and works against the cancer.
Hear when a new Advanced Solid Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.